Structures by: Taş M.
Total: 36
0.25(C120H104N24O32Zn8),0.5(C6H14N2O2)
0.25(C120H104N24O32Zn8),0.5(C6H14N2O2)
Dalton transactions (Cambridge, England : 2003) (2020) 49, 31 10824-10831
a=27.5755(3)Å b=9.94920(10)Å c=15.42700(10)Å
α=90° β=119.4800(10)° γ=90°
C15H14N3O4Zn,I0.31
C15H14N3O4Zn,I0.31
Dalton transactions (Cambridge, England : 2003) (2020) 49, 31 10824-10831
a=27.635(3)Å b=9.8134(10)Å c=15.5781(15)Å
α=90° β=119.807(4)° γ=90°
0.25(C120H96N24O32Zn8),O
0.25(C120H96N24O32Zn8),O
Dalton transactions (Cambridge, England : 2003) (2020) 49, 31 10824-10831
a=27.492(2)Å b=9.7980(8)Å c=15.5864(11)Å
α=90° β=119.541(2)° γ=90°
C14H20CdCuN2O14
C14H20CdCuN2O14
CrystEngComm (2013) 15, 6 1244
a=16.435Å b=7.076Å c=20.060Å
α=90.00° β=107.66° γ=90.00°
C17H31CuN5O4
C17H31CuN5O4
CrystEngComm (2013) 15, 6 1244
a=12.996(5)Å b=22.878(5)Å c=13.696(5)Å
α=90.000(5)° β=93.972(5)° γ=90.000(5)°
C38H50Cu2N10O10
C38H50Cu2N10O10
CrystEngComm (2013) 15, 6 1244
a=11.135Å b=13.601Å c=14.886Å
α=90.00° β=96.37° γ=90.00°
C19H23CdN5O4
C19H23CdN5O4
CrystEngComm (2013) 15, 6 1244
a=13.536Å b=9.938Å c=16.885Å
α=90.00° β=90.00° γ=90.00°
C16H14Ag2N4O8,C4H16CuN4,8(H2O)
C16H14Ag2N4O8,C4H16CuN4,8(H2O)
CrystEngComm (2013) 15, 6 1244
a=23.396(5)Å b=6.654(5)Å c=23.775(5)Å
α=90.00° β=112.26(3)° γ=90.00°
C27H28CuN6O5S,4(H2O)
C27H28CuN6O5S,4(H2O)
Dalton transactions (Cambridge, England : 2003) (2015) 44, 4 1627-1635
a=37.162(5)Å b=8.603(5)Å c=20.236(5)Å
α=90.000(5)° β=100.733(5)° γ=90.000(5)°
C20H20CuN4O4S,4(H2O)
C20H20CuN4O4S,4(H2O)
Dalton transactions (Cambridge, England : 2003) (2015) 44, 4 1627-1635
a=10.1535(5)Å b=16.3971(7)Å c=15.7138(7)Å
α=90.00° β=106.707(2)° γ=90.00°
Bis{1-[(4-methoxyphenyl)amino]-2-methylglyoximato-κ^2^N,N}nickel(II)
C20H24N6NiO6
Acta Crystallographica Section E (2005) 61, 9 m1866-m1868
a=8.8819(7)Å b=5.2497(3)Å c=24.216(2)Å
α=90.00° β=106.165(7)° γ=90.00°
Bis(O,O'-dicyclohexyl phosphorodithioato)nickel(II)
C24H44NiO4P2S4
Acta Crystallographica Section E (2005) 61, 9 m1684-m1685
a=11.7991(6)Å b=9.3550(5)Å c=14.2138(8)Å
α=90.00° β=96.764(5)° γ=90.00°
N-(3-Chloro-4-Metoxyphenyl)-N'-Hydroxy-2-Oxo-2-Phenylacetamidine
C15H13ClN2O3
Acta Crystallographica Section E (2003) 59, 10 o1532-o1534
a=5.0135(7)Å b=12.7483(11)Å c=22.495(3)Å
α=90.00° β=91.553(11)° γ=90.00°
N-Hydroxy-2-oxo-2,N'-diphenylacetamidine
C14H12N2O2
Acta Crystallographica Section E (2003) 59, 6 o883-o885
a=10.0106(9)Å b=10.2280(6)Å c=12.1627(7)Å
α=90.00° β=95.763(6)° γ=90.00°
N-(3-chloro-4-methylphenyl)-N'-hydroxy-2-oxo-2-phenylacetamidine
C15H13ClN2O2
Acta Crystallographica Section E (2004) 60, 3 o406-o408
a=25.6412(14)Å b=4.9773(3)Å c=22.3894(16)Å
α=90.00° β=90.00° γ=90.00°
Bis[N-(2,6-dimethylphenyl)aminophenylglyoximato-κ^2^N,N]nickel(II) dimethyl sulfoxide solvate
C32H32N6NiO4,C2H6OS
Acta Crystallographica Section E (2004) 60, 9 m1334-m1336
a=13.2381(11)Å b=7.8171(4)Å c=16.5034(14)Å
α=90.00° β=94.654(7)° γ=90.00°
N-Hydroxy-N'-(1-naphthyl)-2-phenylacetamidin-2-one
C18H14N2O2
Acta Crystallographica Section E (2004) 60, 1 o109-o111
a=12.0073(11)Å b=8.4530(9)Å c=15.0167(15)Å
α=90.00° β=94.188(8)° γ=90.00°
Bis[1-(2,6-dimethylanilino)propane-1,2-dione dioximato]nickel(II)
C22H28N6NiO4
Acta Crystallographica Section E (2005) 61, 10 m2033-m2035
a=8.1081(4)Å b=16.0311(8)Å c=8.9223(4)Å
α=90.00° β=94.2020(10)° γ=90.00°
3,4,5-Trimethoxybenzoic acid
C10H12O5
Acta Crystallographica Section E (2007) 63, 8 o3456-o3456
a=7.3384(3)Å b=8.8325(3)Å c=15.7560(5)Å
α=90.00° β=96.576(2)° γ=90.00°
Ethyl 2-(3-methoxyphenyl)acetate
C11H14O3
Acta Crystallographica Section E (2007) 63, 12 o4678-o4678
a=14.868(2)Å b=4.851(2)Å c=15.428(4)Å
α=90.00° β=107.70(3)° γ=90.00°
2-[Benzoyl(hydroxyimino)methylamino]benzoic acid
C15H12N2O4
Acta Crystallographica Section C (2004) 60, 4 o263-o264
a=20.6850(19)Å b=13.1680(13)Å c=10.488(11)Å
α=90.00° β=101.921(5)° γ=90.00°
N^1^-(4-tert-Butylphenyl)-N^2^-hydroxy-α-oxo-α-phenylacetamidine
C18H20N2O2
Acta Crystallographica Section C (2004) 60, 9 o702-o704
a=6.4331(10)Å b=10.7150(15)Å c=12.299(2)Å
α=75.054(12)° β=82.120(12)° γ=77.258(11)°
N^1^-(4-nitrophenyl)-N^2^-hydroxy-α-oxo-α-phenylacetamidine hemihydrate
C14H11N3O4,0.5H2O
Acta Crystallographica Section C (2004) 60, 9 o702-o704
a=6.8298(5)Å b=15.5454(15)Å c=26.097(2)Å
α=90.00° β=92.080(7)° γ=90.00°
N^1^-(4-Bromophenyl)-N^2^-hydroxy-2-oxo-2-phenylacetamidine
C14H11BrN2O2
Acta Crystallographica Section C (2005) 61, 5 o343-o344
a=21.593(5)Å b=13.328(5)Å c=9.352(5)Å
α=90.000(5)° β=104.008(5)° γ=90.000(5)°
N^1^-(2,6-Dimethylphenyl)-N^2^-hydroxy-α-oxo-α-phenylacetamidine
C16H16N2O2
Acta Crystallographica Section C (2004) 60, 2 o115-o117
a=8.1002(10)Å b=7.8837(10)Å c=23.108(3)Å
α=90° β=90.828(10)° γ=90°
<i>trans</i>-Bis(nitrato-κ<i>O</i>)tetrakis(1-vinyl-1<i>H</i>-imidazole- κ<i>N</i>^3^)copper(II)
C20H24CuN10O6
Acta Crystallographica Section E (2012) 68, 8 m1045
a=8.9415(4)Å b=8.7618(3)Å c=16.3172(6)Å
α=90.00° β=102.281(4)° γ=90.00°
Pentaaqua(dimethylformamide)cobalt(II) sulfate dimethylformamide monosolvate
C3H17CoNO62,O4S2,C3H7NO
Acta Crystallographica Section E (2013) 69, 7 m373
a=22.256(8)Å b=7.449(7)Å c=9.929(9)Å
α=90.00° β=90.00° γ=90.00°
C14H14CdN3O6,H2O
C14H14CdN3O6,H2O
Crystal Growth & Design (2015) 15, 6 3024
a=8.53400(10)Å b=9.65730(10)Å c=10.26020(10)Å
α=78.93° β=75.6950(10)° γ=76.4000(10)°
C20H13N5O5Zn
C20H13N5O5Zn
Crystal Growth & Design (2015) 15, 6 3024
a=11.8471(2)Å b=18.1104(3)Å c=17.8499(3)Å
α=90° β=90° γ=90°
C22H19N5O6Zn
C22H19N5O6Zn
Crystal Growth & Design (2015) 15, 6 3024
a=11.0990(2)Å b=12.1358(2)Å c=16.4905(2)Å
α=90° β=103.3050(10)° γ=90°
C22H17MnN5O5
C22H17MnN5O5
Crystal Growth & Design (2015) 15, 6 3024
a=8.60730(10)Å b=10.2090(2)Å c=12.6781(2)Å
α=108.2540(10)° β=97.8360(10)° γ=97.3020(10)°
C22H17CdN5O5
C22H17CdN5O5
Crystal Growth & Design (2015) 15, 6 3024
a=8.6453(4)Å b=10.3129(5)Å c=12.7250(6)Å
α=109.491(2)° β=95.535(2)° γ=97.425(2)°
C22H17N5O5Zn
C22H17N5O5Zn
Inorganic chemistry (2015) 54, 23 11283-11291
a=9.9411(3)Å b=15.7636(4)Å c=14.3626(5)Å
α=90.00° β=111.548(2)° γ=90.00°
0.5(C44H34N10O8Zn2)
0.5(C44H34N10O8Zn2)
Inorganic chemistry (2015) 54, 23 11283-11291
a=14.639(2)Å b=21.8314(16)Å c=9.7911(11)Å
α=90° β=90° γ=90°
C22H17N5O5Zn
C22H17N5O5Zn
Inorganic chemistry (2015) 54, 23 11283-11291
a=8.56540(10)Å b=10.18050(10)Å c=12.92450(10)Å
α=76.03° β=88.0460(10)° γ=77.77°
C22H17N5O5Zn
C22H17N5O5Zn
Inorganic chemistry (2015) 54, 23 11283-11291
a=14.2505(6)Å b=8.1972(3)Å c=18.9816(7)Å
α=90.00° β=97.214(2)° γ=90.00°